Yet such studies have generally focused on tau aggregation in the cortex, mainly due to the higher prevalence of disease-specific canonical tau aggregates, and higher overall tau burden in some tauopathies (e.g., AD, PSP). The gene discussed is MAPT; the disease is Alzheimer disease.